HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Semeraro Selected Research

N Semeraro Research Topics

Disease

3Thrombosis (Thrombus)
09/2008 - 04/2001
2Colorectal Neoplasms (Colorectal Cancer)
02/2007 - 07/2003
2Neoplasms (Cancer)
02/2007 - 07/2003
1Hemorrhage
01/2016
1Venous Thromboembolism
09/2008
1Pulmonary Embolism
11/2005
1Dyspepsia (Indigestion)
01/2005
1Infections
01/2005
1Neoplasm Metastasis (Metastasis)
07/2003
1Chronic Granulomatous Disease
04/2001
1Inflammation (Inflammations)
09/2000

Drug/Important Bio-Agent (IBA)

2FibrinIBA
01/2016 - 09/2000
2Antifibrinolytic Agents (Antifibrinolytics)IBA
09/2008 - 01/2005
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2007 - 07/2003
2Thromboplastin (Tissue Factor)IBA
02/2007 - 07/2003
1butyl phosphorotrithioate (DEF)IBA
01/2016
1Factor XI (Plasma Thromboplastin Antecedent)IBA
01/2016
1AnticoagulantsIBA
09/2008
1HomocysteineIBA
09/2008
1ImmunosorbentsIBA
02/2007
1EnzymesIBA
02/2007
1Epinephrine (Adrenaline)FDA LinkGeneric
11/2005
11,2,6,7,8,8a- hexahydro- beta,delta,6- trihydroxy- 2- methyl- 8- (2- methyl- 1- oxobutoxy)- 1- naphthaleneheptanoic acid 4-(nitrooxy)butyl esterIBA
11/2005
1CollagenIBA
11/2005
1Proteins (Proteins, Gene)FDA Link
01/2005
1Prothrombin (Factor II)IBA
01/2005
1fibrin fragment D (D-dimer)IBA
01/2005
1Plasminogen Activator Inhibitor 1IBA
01/2005
1Plasminogen Activator Inhibitor 2IBA
01/2005
1Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA
01/2005
1NADPH Oxidases (NAD(P)H oxidase)IBA
04/2001

Therapy/Procedure

2Therapeutics
09/2008 - 02/2007
1Thrombolytic Therapy
04/2001